Evidence ยท Children and gender
What did the 2025 HHS review find on puberty blockers, hormones and surgery for minors?
A plain-language guide to the federal review of sex-rejecting procedures for children and teenagers, and to the reviews in other countries that reached the same conclusions.
The short answer
The U.S. Department of Health and Human Services (HHS) found no reliable evidence that puberty blockers, cross-sex hormones or surgery help children with gender dysphoria. It documented serious harms, many of them permanent, including infertility, loss of sexual function, bone loss and regret. Health authorities in England, Finland, Sweden, Norway and France have pulled back from these procedures for minors. The harms do not go away at 18.
What the review is
The review is titled Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices. HHS prepared it under an executive order signed on January 28, 2025. HHS released a first version on May 1, 2025, and the final, peer-reviewed version on November 19, 2025.
This page uses the term sex-rejecting procedures. It means puberty blockers, cross-sex hormones and surgeries such as mastectomies, used to make a child's body look more like the opposite sex. Our toolkit for parents explains why benign-sounding labels hide how serious these procedures are.
What it found
No reliable evidence of benefit
The authors pooled the existing systematic reviews. They rated the certainty of evidence as very low for psychological outcomes, quality of life, regret and long-term health. In plain terms, the studies give no dependable sign that these procedures help children.
The harms are serious and often permanent
The review lists infertility, sexual dysfunction, lower bone density, effects on thinking and memory, heart and metabolic problems, psychiatric problems, surgical complications and regret. Studies track harms poorly, so the research likely undercounts them. The report says that known harms and unproven benefits raise serious questions of medical ethics about offering these procedures to minors at all.
The harms do not end at 18
A removed breast does not grow back, and lost fertility does not return, at any age. Our toolkit for parents explains why minors cannot give informed consent to these procedures. Children cannot weigh effects that last a lifetime, such as sterility, chronic pain and loss of sexual function.
Psychotherapy shows no evidence of harm
Systematic reviews found no evidence of harm from psychotherapy for gender dysphoria. The evidence is stronger for treating conditions that often come with it, such as anxiety and depression. HHS puts counseling and non-medical support first.
Do these procedures prevent suicide?
The evidence does not show that they do. A 2024 Finnish study of more than 2,000 young people referred to gender services found that, once mental health treatment was taken into account, their suicide rate matched that of their peers. Underlying psychiatric conditions predicted suicide. Gender dysphoria did not.
A 2025 systematic review of cross-sex hormones rated the evidence on suicide as very low certainty. A 2026 study by Do No Harm found no evidence that state laws restricting these procedures raised teen suicide rates.
Other countries reached the same conclusions
England's National Health Service asked Dr. Hilary Cass, a pediatrician, to review its gender service for young people. The final Cass Review came out in April 2024. Dr. Cass called the evidence "disappointingly poor." Systematic reviews by the University of York rated the quality of the studies it relied on:
England closed the Tavistock clinic, once the world's largest pediatric gender clinic, and the UK government restricted the prescribing and supply of puberty blockers for minors. Other countries changed course after their own reviews:
- Finland, 2020. National guidelines made psychosocial support and psychotherapy the first-line approach and limited hormones to carefully selected cases.
- Sweden, 2022. The National Board of Health and Welfare concluded that the risks of puberty blockers and cross-sex hormones likely outweigh the benefits.
- Norway, 2023. An independent board found the evidence for hormonal and surgical treatment of young people insufficient.
- France, 2022. The National Academy of Medicine called for "great medical caution" with children and adolescents.
- New Zealand, 2025. The government banned new puberty blocker prescriptions for gender dysphoria. A court has paused enforcement while a legal challenge proceeds.
The World Health Organization declined to issue guidance for children because the evidence is "limited and variable."
What HHS found in 2026
A follow-up HHS investigation, Wolves in White Coats, found nearly $120 million in billed charges for sex-rejecting procedures on minors from 2019 to 2023. That total includes more than 5,500 surgical procedures and 8,500 courses of hormones or puberty blockers. Surgeries ranged from about $12,000 to more than $130,000. The report found that these procedures turn children into lifelong "captive patients" who need visits, lab tests, prescriptions and follow-up care into adulthood.
Who disagrees, and why
The American Academy of Pediatrics and the Endocrine Society still promote these procedures for minors. The 2026 HHS report found that these groups did so "even while undercutting their own evidence base." A Manhattan Institute analysis finds that U.S. medical groups get the science wrong. In February 2026, the American Society of Plastic Surgeons recommended that surgeons delay gender-related breast, chest, genital and facial surgery until a patient is at least 19.
Critics also attacked England's Cass Review. Many of those attacks rely on a single report from Yale Law School, whose errors and conflicts of interest are documented in detail.
Who wrote it
HHS names nine authors in the final report: Evgenia Abbruzzese, Alex Byrne, Farr Curlin, Moti Gorin, Kristopher Kaliebe, Michael K. Laidlaw, Kathleen McDeavitt, Leor Sapir and Yuan Zhang. Five of them disclosed payments related to work in this field. Disclosure: Dr. Kaliebe also co-authored Restore Childhood's toolkit for parents.
The law
On June 18, 2025, the U.S. Supreme Court upheld Tennessee's law in United States v. Skrmetti. The law bans puberty blockers, cross-sex hormones and surgery for gender dysphoria in minors. In that ruling, the Court noted that more than 20 states have passed laws banning these procedures for minors. In 2026, a Westchester County jury awarded $2 million to Fox Varian, who had a double mastectomy at 16 and later detransitioned. The jury found her providers failed to meet the standard of care.
Watch
Dr. Kris Kaliebe, child and adolescent psychiatrist and co-author of the Gender Toolkit, on why medicine for children must rest on evidence and open debate.
What you can do now
- Read the HHS executive summary yourself. It is short and written for a general reader.
- If a clinician recommends puberty blockers, hormones or surgery for your child, ask for the evidence and the risks in writing.
- Ask whether your child has been screened for anxiety, depression, autism or trauma, and how those will be treated.
- Learn your state's current law. Our free toolkit for parents includes a state-by-state guide.
Related
This page explains public research. It is not medical advice for any person. We update it as new research comes out. If you see an error, please contact us.